Samsung C&T's construction division saw Q3 revenue and profit plunge, but robust bio business growth and anticipated high-tech investments signal a 2025 rebound.
#YonhapInfomax #SamsungCT #ConstructionDivision #Q3Earnings #BioDivision #HighTechInvestment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=87779
#YonhapInfomax #SamsungCT #ConstructionDivision #Q3Earnings #BioDivision #HighTechInvestment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=87779